Genome editing and gene regulation in industrial bacterial biotechnology

CRISPR “spacer” sequences are transcribed into short RNA sequences (“CRISPR RNAs” or “crRNAs”) capable of guiding the system to matching sequences of DNA. When the target DNA is found, Cas9 – one of the enzymes produced by the CRISPR system – binds to the DNA and cuts it, shutting the targeted gene off. Using modified versions of Cas9, researchers can activate gene expression instead of cutting the DNA. These techniques allow researchers to study the gene’s function.

Research also suggests that CRISPR-Cas9 can be used to target and modify “typos” in the three-billion-letter sequence of the human genome in an effort to treat genetic disease

    Related Conference of Genome editing and gene regulation in industrial bacterial biotechnology

    June 08-09, 2026

    9th Global Conference on Cell and Gene Therapy

    Rome, Italy
    June 18-19, 2026

    19th International Conference on Genomics & Pharmacogenomics

    Singapore City, Singapore
    September 25-26, 2025

    6th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada

    Genome editing and gene regulation in industrial bacterial biotechnology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in